课题基金 / 基金详情

DEFINITION OF HUMAN HISTOCOMPATIBILITY ANTIGENS

DEFINITION OF HUMAN HISTOCOMPATIBILITY ANTIGENS
人类组织相容性抗原的定义
批准号:
3939238
负责人:
S SHAW
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

S SHAW的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Using T cell recognition (primarily cell-mediated lysis) we have continued to probe the complexities of T cell recognition of HLA alloantigens. We have pursued the novel approach of using cytotoxic T lymphocyte (CTL) clones as the selective agent to enrich for ICR-191 mutagenized lymphoblastoid cell lines (LCL) which have lost their capacity to be lysed by that clone. Using that approach, 24 mutant LCL have been derived which are not lysed by the "selecting" DPw2-allospecific CTL clone. Serological analysis confirms the loss of DPw2 and Nothern blot analysis demonstrates loss of DP alpha or DP beta mRNA in many of the mutants. These mutants have subsequently been used as informative probes to demonstrated the requirement for DP alpha and DP beta recognition by other putatively "DPw2-specific" CTL clones with more complex specificity. The specificity of these clones suggests that they may recognize peptide fragments of another HLA gene(s) in a DP-restricted fashion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MECHANISMS OF CELLULAR IMMUNE RESPONSES
MECHANISMS OF HUMAN IN VITRO CELLULAR IMMUNE RESPONSES
MECHANISMS OF CELLULAR IMMUNE RESPONSES
MECHANISMS OF CELLULAR IMMUNE RESPONSES
海外基金